Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy BLOOD Meyer, R. M., Hoppe, R. T. 2012; 120 (23): 4488-4495

Abstract

The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.

View details for DOI 10.1182/blood-2012-05-423236

View details for Web of Science ID 000313113300011

View details for PubMedID 22821764

View details for PubMedCentralID PMC3512228